Barry Hafkin

Linezolid versus Vancomycin for the Treatment of Methicillin‐Resistant <i>Staphylococcus aureus</i> Infections

Dennis L. Stevens, Daniel Herr, Harry Lampiris et al. · Clinical Infectious Diseases · 2002 · 511 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Hematologic Effects of Linezolid: Summary of Clinical Experience

Stanton L. Gerson, Sheldon L. Kaplan, Jon Bruss et al. · Antimicrobial Agents and Chemotherapy · 2002 · 443 citations · Full text

Medicine, Hematology, Pharmacology +14

Randomized Comparison of Linezolid (PNU-100766) versus Oxacillin-Dicloxacillin for Treatment of Complicated Skin and Soft Tissue Infections

Dennis L. Stevens, Leon G. Smith, Jon B. Bruss et al. · Antimicrobial Agents and Chemotherapy · 2000 · 241 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Worldwide Assessment of Linezolid's Clinical Safety and Tolerability: Comparator-Controlled Phase III Studies

Ethan Rubinstein, Raúl Istúriz, Harold C. Standiford et al. · Antimicrobial Agents and Chemotherapy · 2003 · 176 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Comparison of Length of Hospital Stay for Patients with Known or Suspected Methicillin‐Resistant <i>Staphylococcus</i> Species Infections Treated with Linezolid or Vancomycin: A Randomized, Multicenter Trial

Zhiming Li, Richard J. Willke, Lionel Pinto et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2001 · 129 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +14